Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Oncotelic Therapeutics, Inc. | d263280d8k.htm |
Exhibit 16.1
December 14, 2016
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated December 9, 2016, of Mateon Therapeutics, Inc. and are in agreement with the statements contained in the first, second, third, and fifth paragraphs on page 2 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP